New Year’s Honours Recognises Experts From Imperial College London
Imperial’s academics are among those to be recognised in the 2023 New Year’s Honours List.
Sir David Nunes Nabarro has been made a Knight Commander of the Order of St Michael and St. George (KCMG) for his services to global health.
Sir David is Co-Director and Chair of Global Health at Imperial’s Institute of Global Health Innovation, which he was appointed in 2019. He is also Strategic Director of the Swiss-based social enterprise, 4SD (Skills Systems and Synergies for Sustainable Development), established in 2017, training and mentoring leaders for sustainable development.
In March 2020, he was appointed Special Envoy of WHO Director-General on COVID-19. He is also co-chair of the World Innovation Summit for Health Forum on Climate Change and Health.
EMERITUS PROFESSOR SUNIL SHAUNAK OBE
Emeritus Professor Sunil Shaunak has been recognised for his services to infectious diseases and drug discovery with an OBE.
Professor Sunil Shaunak, Emeritus Professor in Infectious Diseases
Professor Shaunak works in Imperial College London’s Department of Infectious Disease and is based at the College’s Hammersmith campus. Over the past 40 years he has developed cost-effective new medicines for Hepatitis C, leishmaniasis, AIDS and Shigella. As co-Founder of the Imperial spinout, PolyTherics (renamed Abzena when it was listed on AIM), he expanded the work into antibody drug conjugates.
“Through our work, we’ve contributed to improving people’s health worldwide. I’m delighted to be honoured in this way and give thanks to colleagues who have helped turn ideas into reality.”
Emeritus Professor Sunil Shaunak
Professor Shaunak has championed the international public debate about the need for equitable global access to affordable medicines. These can be modelled on expensive drugs, but structurally modified to make them both patentable (he has 23 granted patents) and cost-effective as new medicines. His work shows how university-based innovation can be turned into useful and affordable global healthcare products.
Responding to the news about his OBE, Professor Shaunak said: “We set out to turn our blue-sky research into cost-effective new medicines and called our approach Ethical Pharmaceuticals. It’s now widely accepted for enabling better access to affordable healthcare products. Through our work, we’ve contributed to improving people’s health worldwide. I’m delighted to be honoured in this way and give thanks to colleagues who have helped turn ideas into reality.”
Professor Jonathan Waxman, Emeritus Professor of Oncology
Professor Jonathan Waxman, Emeritus Professor of Oncology at the Hammersmith Hospital, London has been made an OBE for services to prostate cancer awareness and treatment.
Professor Waxman is a clinician who has helped develop new treatments for cancer and who directed a laboratory research group that comprised 40 scientists whose focus was and is the development of new cancer treatments and tests.
He has raised funds for the building of the Hammersmith Cancer Centre at Imperial whose spirit aims to combine the best of conventional and alternative therapies.
He founded Prostate Cancer UK the first UK based national organisation promoting research and patient support for this condition which affects 1 man in 8. The Charity currently raises £35 million per annum and employs 200 people. He has played a significant role in bringing prostate cancer to the forefront of public attention. As a result prostate cancer has emerged from the shadows and is talked about and appropriately funded.
He also helped establish an All Party Parliamentary Group to improve cancer treatment and rationalise cancer research throughout the UK. He has developed and led successful media campaigns to rationalise cancer treatments and change government health policy.
Reacting to the news of his award, Professor Waxman said: “I was thrilled to receive this award, which acknowledges both the work done at Imperial to help men with prostate cancer and the evolution of Prostate Cancer UK to become the UK’s biggest men’s health charity.”